Showing 101-110 of 595 results for "".
Sleep Disturbances and Psychological Burden of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/sleep-disturbances-and-psychological-burden-of-prurigo-nodularis/37182/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the impact of itch from prurigo nodularis on quality of life through sleep disturbances and mental health effects.Sleep Disturbances and Psychological Burden of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/sleep-disturbances-and-psychological-burden-of-prurigo-nodularis/48790/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the impact of itch from prurigo nodularis on quality of life through sleep disturbances and mental health effects.Dysregulation of Type 2 Immune Pathway
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/dysregulation-of-type-2-immune-pathway/48788/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the role of type 2 inflammatory response in immune dysregulation in atopic dermatitis.DERM2021: An Engaging Learning Experience
https://practicaldermatology.com/series/dermatology-education-foundation/derm2021-an-engaging-learning-experience/19967/Joe Gorelick, MSN, FNP-BC, DEF President, is excited for this year’s DERM2021 NP/PA CME Conference that offers meaningful case studies presented by an advisory panel of dermatology nurse practitioners and physician assistants for an engaging learning experience.Navigating the Latest Therapeutic Options
https://practicaldermatology.com/issues/october-2025/navigating-the-latest-therapeutic-options/39762/A Q&A With Raj Chovatiya, MD, PhD, MSCI, FAADLive in Las Vegas: Get Ready for DERM2021
https://practicaldermatology.com/series/dermatology-education-foundation/live-in-las-vegas-get-ready-for-derm2021/19968/The DERM2021 NP/PA CME Conference offers dermatology physician assistants and nurse practitioners an opportunity to stay up to date on the latest products, drugs, and treatments in dermatology to improve care for patients. Joe Gorelick, MSN, FNP-BC, DEF President, says this year’s conference is goinMerkel Cell Carcinoma Update
https://practicaldermatology.com/topics/skin-cancer-photoprotection/merkel-cell-carcinoma-update/20217/News that “Margaritaville” singer Jimmy Buffett died from Merkel cell carcinoma is shining a spotlight on this rare and aggressive form of skin cancer. Leonel Hernandez Aya, MD, a medical oncologist specializing in skin cancers at the Sylvester Comprehensive Cancer Center at the University of MiamiEvaluating Roflumilast for Seborrheic Dermatitis
https://practicaldermatology.com/series/skin-minute/evaluating-roflumilast-for-seborrheic-dermatitis/54610/Practical Dermatology Editorial Board member Raj Chovatiya, MD, PhD, MSCI, discusses results from the Phase 3 STRATUM trial studying the efficacy of roflumilast for the treatment of seborrheic dermatitis in patients with diverse skin types.IL-31’s Role in Prurigo Nodularis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/il-31s-role-in-prurigo-nodularis/48804/Raj Chovatiya, MD, PhD, MSCI, FAAD, explains the role of the IL-31 pathway in neuroinflammatory disease such as prurigo nodularis.Psoriasis Update 2025: Dr. Gelfand
https://practicaldermatology.com/programs/practical-dermatology/psoriasis-update-2025-dr-gelfand/32672/Joel Gelfand, MD, MSCE, discusses highlights from the "Psoriasis Update 2025" panel at Maui Derm 2025, including the potential for combining TNF inhibitors with IL-23 inhibitors; home phototherapy; and the possibility of GLP-1 agonists lowering the severity of psoriatic disease.